ResMed
RMD
$183.42
Share price
-0.20%
Change (1 day)
-19.06%
Change (1 year)
Categories
Operating Margin for ResMed (RMD)
Operating Margin as of April 2024 (TTM): 26.84%
According to ResMed's latest financial reports and stock price the company's current Operating Margin is 26.84%. At the end of 2022 the company had an Operating Margin of 26.84%.
Operating Margin history for ResMed from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 26.84% | -2.89% |
| 2021 | 27.64% | 11.5% |
| 2020 | 24.79% | 24.55% |
| 2019 | 19.91% | -10.64% |
| 2018 | 22.28% | 9.95% |
| 2017 | 20.26% | -15.25% |
| 2016 | 23.91% | -7.93% |
| 2015 | 25.96% | -6.34% |
| 2014 | 27.72% | 9.02% |
| 2013 | 25.43% | 4.84% |
| 2012 | 24.26% | -0.71% |
| 2011 | 24.43% | 2.41% |
| 2010 | 23.86% | 8.91% |
| 2009 | 21.90% | 15.92% |
| 2008 | 18.90% | 38.16% |
| 2007 | 13.68% | -37.76% |
| 2006 | 21.98% | -3.23% |
| 2005 | 22.71% | -8.99% |
| 2004 | 24.95% | 1.69% |
| 2003 | 24.54% | -8.27% |
| 2002 | 26.75% | 51.96% |
| 2001 | 17.60% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 17.17% | -36.03% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 14.17% | -47.21% | 🇺🇸 USA |
 Masimo MASI | 9.49% | -64.64% | 🇺🇸 USA |
 Allied Healthcare Products AHPI | -17.60% | -165.57% | 🇺🇸 USA |
 Inogen INGN | -11.22% | -141.80% | 🇺🇸 USA |
 Philips PHG | -9.70% | -136.14% | 🇳🇱 Netherlands |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.